Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City.

Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, Kreiswirth BN, Jenkins SG.

PLoS One. 2012;7(9):e45141. doi: 10.1371/journal.pone.0045141. Epub 2012 Sep 20.

2.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital.

Briggs S, Ussher J, Taylor S.

N Z Med J. 2005 Jul 15;118(1218):U1563.

PMID:
16027752
3.

Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB.

Antimicrob Agents Chemother. 2009 Jun;53(6):2539-43. doi: 10.1128/AAC.00061-09. Epub 2009 Apr 13.

4.

[Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].

Bayraktar B, Toksoy B, Bulut E.

Mikrobiyol Bul. 2010 Apr;44(2):187-96. Turkish.

PMID:
20549952
5.

Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.

Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, André C; Scientific Committee of ONERBA.

J Antimicrob Chemother. 2009 Jun;63(6):1205-14. doi: 10.1093/jac/dkp108. Epub 2009 Mar 28.

PMID:
19329798
6.

Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.

Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK.

Int J Antimicrob Agents. 2009 Dec;34(6):544-9. doi: 10.1016/j.ijantimicag.2009.07.014. Epub 2009 Sep 11.

PMID:
19748232
7.

Colonization of returning travelers with CTX-M-producing Escherichia coli.

Peirano G, Laupland KB, Gregson DB, Pitout JD.

J Travel Med. 2011 Sep-Oct;18(5):299-303. doi: 10.1111/j.1708-8305.2011.00548.x. Epub 2011 Aug 15.

8.

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.

J Antimicrob Chemother. 2006 Apr;57(4):780-3. Epub 2006 Feb 21.

PMID:
16492721
9.

Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.

Peirano G, Costello M, Pitout JD.

Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.

PMID:
20359869
10.

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.

Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JD.

Antimicrob Agents Chemother. 2010 Mar;54(3):1327-30. doi: 10.1128/AAC.01338-09. Epub 2010 Jan 4.

11.

Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland.

Khanna N, Boyes J, Lansdell PM, Hamouda A, Amyes SG.

J Antimicrob Chemother. 2012 Mar;67(3):573-7. doi: 10.1093/jac/dkr523. Epub 2011 Dec 14.

PMID:
22169188
12.

Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance.

Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, Justesen US, Frimodt-Møller N; DANRES Study Group.

Scand J Infect Dis. 2012 Mar;44(3):174-81. doi: 10.3109/00365548.2011.632642.

PMID:
22364227
13.

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y.

Clin Infect Dis. 2009 Sep 1;49(5):682-90. doi: 10.1086/604713.

PMID:
19622043
14.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.

Schoevaerdts D, Bogaerts P, Grimmelprez A, de Saint-Hubert M, Delaere B, Jamart J, Swine C, Glupczynski Y.

BMC Infect Dis. 2011 Jan 12;11:12. doi: 10.1186/1471-2334-11-12.

15.

Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.

Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.

J Antimicrob Chemother. 2009 Apr;63(4):781-4. doi: 10.1093/jac/dkp028. Epub 2009 Feb 17.

PMID:
19223299
16.

Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.

Garza-González E, Mendoza Ibarra SI, Llaca-Díaz JM, Gonzalez GM.

J Med Microbiol. 2011 Jan;60(Pt 1):84-90. doi: 10.1099/jmm.0.022970-0. Epub 2010 Oct 7.

PMID:
20930052
17.

CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.

Martinez P, Garzón D, Mattar S.

Braz J Infect Dis. 2012 Sep-Oct;16(5):420-5. doi: 10.1016/j.bjid.2012.05.001. Epub 2012 Sep 8.

18.

Enterobacteriaceae bacteremia: risk factors for ESBLPE.

Neulier C, Birgand G, Ruppé É, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A.

Med Mal Infect. 2014 Jan;44(1):32-8. doi: 10.1016/j.medmal.2013.11.003. Epub 2013 Dec 8.

PMID:
24321202
19.

Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.

Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez-Gil González M, Gómez-Nieto A, Palacios-Martín T, González-Sagrado M, Dueñas-Laita A, Pérez-Castrillón JL.

Int J Clin Pract. 2012 Sep;66(9):891-6. doi: 10.1111/j.1742-1241.2012.02991.x.

PMID:
22897466
20.

Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.

Fennell J, Vellinga A, Hanahoe B, Morris D, Boyle F, Higgins F, Lyons M, O'Connell K, Keady D, Cormican M.

BMC Infect Dis. 2012 May 15;12:116. doi: 10.1186/1471-2334-12-116.

Supplemental Content

Support Center